Sort by
Refine Your Search
-
antimicrobial drug development. The successful candidate will work closely with researchers across both laboratories and the wider project team. Te mahi | The role This position is part of the Wellcome Leap
-
trial which is being funded by the Wellcome Trust. ENERGISE-BD is a phase III RCT of a keto-genic diet vs NHS eat well plan, for people with bipolar disorder depression. It is being co-led by
-
. The Wellcome Bioimaging project to accelerate cutting-edge bioimaging technology development, is a five-year cross-disciplinary programme, led by Professor Maddy Parsons from the School of Basic & Medical
-
their microenvironment in chronic liver disease and liver cancer. This is a highly collaborative and cross-institutional role between the Francis Crick Institute and the Wellcome Sanger Institute. Working closely with
-
general aim is to develop new conceptual frameworks and models for the study of biological complexity, focusing on the intersection of development and evolution. The research group is primarily theoretical
-
£54,843. Grade: Clinical Full Time, Fixed Term contract up to 2 years Closing date: 21st July 2026 UK Travel may be required for this role Background Funded by the Wellcome Trust, ENERGISE-BD is a phase III